Related Experiment Video
Updated: Jan 20, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Progress in the Discovery of Small Molecule Modulators of DeSUMOylation
Shiyao Chen1, Duoling Dong1, Weixiang Xin1
1School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.
Abstract:
SUMOylation and DeSUMOylation are reversible protein post-translational modification (PTM) processes involving small ubiquitin-like modifier (SUMO) proteins. These processes have indispensable roles in various cellular processes, such as subcellular localization, gene transcription, and DNA replication and repair. Over the past decade, increasing attention has been given to SUMO-related pathways as potential therapeutic targets. The Sentrin/SUMO-specific protease (SENP), which is responsible for deSUMOylation, has been proposed as a potential therapeutic target in the treatment of cancers and cardiac disorders. Unfortunately, no SENP inhibitor has yet reached clinical trials. In this review, we focus on advances in the development of SENP inhibitors in the past decade.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Molecules and Compounds
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Positive Regulator Molecules
Types of Signaling Molecules

